Big news, and exciting times!

QUINTA-ANALYTICA are very happy to announce new investment from renowned family equity firm BBA CapitalPartners.

As an established provider of R&D and regulatory services for the pharmaceutical, biotechnology, and generic drug industries, Quinta today announced an investment change as Genesis Capital Equity passed their majority stake to LVA Holding GmbH, a portfolio company of BBA Capital Partners (BBA).

With over two decades of development and innovation under its belt, Quinta is a provider of services to the global pharmaceutical market and offers a wide portfolio of services, a diversified client portfolio, and presence in Europe and North America.

Roman Grunt, CEO, and Chairman of the Board of Directors of Quinta stated: “This move is another step for Quinta and its people on our growth path. Genesis supported our development projects and together we managed to overcome difficult years. I sincerely thank Jan Tauber and the entire Genesis team for this”.

He continued that “We are now looking forward to moving ahead with our new partner. We knew this change must come and I am delighted that it is BBA. Today we have a chance to not only keep Quinta’s essence, but with the network and financial support of our new partner we will grow further and play a leading role in building the pharma division within BBA’s portfolio”.

Concluding with recognition of his team he added “I can also not thank our management team enough, including CCO Jiri Raska, and CSO Marcela Písačková, as well as all of our employees and partners for where we are today. With this wind in our back, we strive to go further and provide the best possible service to our customers“.

Also commenting on the move, Felix Burgdorf, Managing Director and Co-Founder of BBA, stated: “Quinta is a leading independent partner for pharmaceutical companies, ensuring pharmaceutical drugs are safely and rapidly brought to those who need them. Their focus on its customers, high quality, scientific excellence, and flexibility differentiates it in the market. We are excited to partner with the top management team and employees to continue to be a reliable partner as well as to sustainably and responsibly develop further to the benefit of end-consumers.”

Learn more about Quinta-Analytica by getting in touch with us, and read the official press release at

Additional News

  • 18 March 2024

    News from our newly opened clinic in Ostrava

    Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.